RA Capital Management 13F holdings, Q3 2010
Holdings as of September 30, 2010 · filings on SEC EDGAR · latest filing →
RA Capital Management disclosed 18 US equity positions worth $101.4m in its Q3 2010 13F filing. The largest position was BSTC at 16.6% of the reported book, followed by ARTHROCARE CORP and ALXN. Against the Q1 2010 filing, it opened 9 new positions, added to 5 and reduced 4 among the top 18 holdings.
What did RA Capital Management own in Q3 2010? Top 18 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2010 |
|---|---|---|---|---|---|---|---|
| 1 | BSTC BIOSPECIFICS TECHNOLOGIES CO | 16.6% | $16.8m | 624,917 | 2% | added | |
| 2 | ARTHROCARE CORP | 10.0% | $10.1m | 373,292 | 15% | added | |
| 3 | ALXN ALEXION PHARMACEUTICALS INC | 9.6% | $9.7m | 151,300 | 4% | added | |
| 4 | PHARMASSET INC | 8.3% | $8.4m | 285,261 | -13% | reduced | |
| 5 | JAZZ PHARMACEUTICALS INC | 8.1% | $8.2m | 767,670 | – | new | |
| 6 | VALEANT PHARMACEUTICALS INTL | 7.6% | $7.7m | 306,200 | – | new | |
| 7 | ALLERGAN INC | 7.2% | $7.3m | 109,200 | – | new | |
| 8 | DEPOMED INC | 5.9% | $6.0m | 1,337,582 | -54% | reduced | |
| 9 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 5.5% | $5.5m | 98,700 | -24% | reduced |
| 10 | CELG CELGENE CORP | 4.8% | $4.9m | 84,600 | – | new | |
| 11 | CUBIST PHARMACEUTICALS INC | 4.7% | $4.8m | 203,100 | – | new | |
| 12 | CYPRESS BIOSCIENCES INC | 3.8% | $3.9m | 1,000,000 | 167% | added | |
| 13 | AASTROM BIOSCIENCES INC | 2.5% | $2.5m | 1,644,838 | 62% | added | |
| 14 | SEQUENOM INC | 2.4% | $2.5m | 350,000 | – | new | |
| 15 | MAP PHARMACEUTICALS INC | 1.1% | $1.1m | 75,000 | – | new | |
| 16 | PSIVIDA CORP | 1.0% | $1.0m | 231,300 | -75% | reduced | |
| 17 | NPS PHARMACEUTICALS INC | 0.7% | $684.0k | 100,000 | – | new | |
| 18 | VISION--SCIENCES INC DEL | 0.3% | $298.0k | 250,679 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.